About Bruker Cellular Analysis
Bruker Cellular Analysis is a company based in New Haven (United States) founded in 2012 was acquired by Berkeley Lights in December 2022. It operates as a Technology-as-a-Service, and Professional Services. Bruker Cellular Analysis has raised $185.85 million across 16 funding rounds from investors including KeyBank, NIH and BlackRock. The company has 195 employees as of December 31, 2022. Bruker Cellular Analysis offers products and services including Beacon Discovery™, IsoLight System, and T Cell Profiling Kit. Bruker Cellular Analysis operates in a competitive market with competitors including 10X Genomics, Guardant Health, Foundation Medicine, ArcherDX and Natera, among others.
- Headquarter New Haven, United States
- Employees 195 as on 31 Dec, 2022
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Bruker Cellular Analysis
-
Annual Revenue
$16.76 M-3as on Dec 31, 2022
-
Net Profit
-
EBITDA
-
Total Equity Funding
$185.85 M (USD)
in 16 rounds
-
Latest Funding Round
$92.5 M (USD), Series D
Jan 07, 2021
-
Investors
KeyBank
& 15 more
-
Employee Count
195
as on Dec 31, 2022
-
Acquired by
Berkeley Lights
(Dec 21, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Bruker Cellular Analysis
Bruker Cellular Analysis offers a comprehensive portfolio of products and services, including Beacon Discovery™, IsoLight System, and T Cell Profiling Kit. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Live single-cell analysis is enabled for research purposes.
Single-cell proteomic signatures are captured for analysis purposes.
T cell functions are profiled for therapeutic discovery.
Unlock access to complete
Unlock access to complete
Software Development Team
43 people
Leadership Team
37 people
Finance and Accounting
29 people
Sales and Marketing
29 people
Legal and Compliance
13 people
Field Team
11 people
Senior Team
10 people
Accounts Team
8 people
Unlock access to complete
Funding Insights of Bruker Cellular Analysis
Bruker Cellular Analysis has successfully raised a total of $185.85M across 16 strategic funding rounds. The most recent funding activity was a Series D round of $92.5 million completed in January 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 16
- Last Round Series D — $92.5M
-
First Round
First Round
(10 Jun 2014)
- Investors Count 15
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2021 | Amount | Debt – Conventional - Bruker Cellular Analysis | Valuation |
investors |
|
| Jan, 2021 | Amount | Series D - Bruker Cellular Analysis | Valuation | Perceptive Advisors | |
| Jun, 2020 | Amount | Grant - Bruker Cellular Analysis | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Bruker Cellular Analysis
Bruker Cellular Analysis has secured backing from 16 investors, including venture fund and institutional investors. Prominent investors backing the company include KeyBank, NIH and BlackRock. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Health-tech companies are targeted for venture capital investments.
|
Founded Year | Domain | Location | |
|
Private equity and hedge fund investments in healthcare are managed.
|
Founded Year | Domain | Location | |
|
Venture capital firm investing in life sciences & tech sectors
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Bruker Cellular Analysis
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Bruker Cellular Analysis
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Bruker Cellular Analysis Comparisons
Competitors of Bruker Cellular Analysis
Bruker Cellular Analysis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as 10X Genomics, Guardant Health, Foundation Medicine, ArcherDX and Natera, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Instrument systems for genomic research and sequencing libraries are developed.
|
|
| domain | founded_year | HQ Location |
Digital sequencing technology for cancer detection is developed.
|
|
| domain | founded_year | HQ Location |
Genomics-based diagnostic tests for cancer are provided.
|
|
| domain | founded_year | HQ Location |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| domain | founded_year | HQ Location |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| domain | founded_year | HQ Location |
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Bruker Cellular Analysis
Frequently Asked Questions about Bruker Cellular Analysis
When was Bruker Cellular Analysis founded?
Bruker Cellular Analysis was founded in 2012 and raised its 1st funding round 2 years after it was founded.
Where is Bruker Cellular Analysis located?
Bruker Cellular Analysis is headquartered in New Haven, United States. It is registered at New Haven, Connecticut, United States.
Is Bruker Cellular Analysis a funded company?
Bruker Cellular Analysis is a funded company, having raised a total of $185.85M across 16 funding rounds to date. The company's 1st funding round was a Grant of $2M, raised on Jun 10, 2014.
How many employees does Bruker Cellular Analysis have?
As of Dec 31, 2022, the latest employee count at Bruker Cellular Analysis is 195.
What is the annual revenue of Bruker Cellular Analysis?
Annual revenue of Bruker Cellular Analysis is $16.76M as on Dec 31, 2022.
What does Bruker Cellular Analysis do?
Bruker Cellular Analysis is engaged in pioneering live single-cell, multimodal, and temporal functional analysis to accelerate scientific breakthroughs. Solutions are provided for antibody discovery, T cell profiling, and cell line development in the optofluidic domain. Proteomic barcoding tools are offered to capture cytokine and phosphoprotein signatures for disease prediction. The company serves sectors like cancer immunology, cell and gene therapy, infectious diseases, inflammation, neurology, and oncology. Platforms such as Beacon Discovery and IsoLight are designed for academic, translational, and biotech research labs.
Who are the top competitors of Bruker Cellular Analysis?
Bruker Cellular Analysis's top competitors include Guardant Health, Strand Life Sciences and Foundation Medicine.
What products or services does Bruker Cellular Analysis offer?
Bruker Cellular Analysis offers Beacon Discovery™, IsoLight System, and T Cell Profiling Kit.
Who are Bruker Cellular Analysis's investors?
Bruker Cellular Analysis has 16 investors. Key investors include KeyBank, NIH, BlackRock, Yale University, and Berkeley Lights.